 NASHVILLE, Tenn., June 14, 2021 GLOBE NEWSWIRE -- Harrow Health, Inc. NASDAQ: HROW Harrow Health or the Company, an ophthalmic-focused healthcare company, today announced that it has commenced an underwritten registered public offering of 17.5 million aggregate principal amount of its 8.625 senior notes due 2026 the Notes, subject to market and certain other conditions. The Notes will be treated as a single series with the Companys outstanding 8.625 senior notes due 2026 and will trade interchangeably with the existing notes. The Company expects to grant the underwriters a 30-day option to purchase additional senior notes in connection with the offering. 